Collaboration Leverages the Foundation's IBD Plexus® Research Accelerator with PhaseV's AI/ML Solutions to Overcome Key Challenges in Clinical Development and Enhance Personalized Treatment ...

Fight Dengue campaign, Civil Surgeon Dr Sangeeta Jain visited various places in district today. Along with a team of senior ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

The move comes after repeated power outages during peak summer last year due to overloading at several substations, discom ...

(July 8-10, 2025). Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox Elad Berkman is co-founder and CTO of PhaseV, which specialises in causal machine ...

The city council for Driggs heard the argument for their approval of the final phase of the Creekside V development, located ...

It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...

Results from the randomized phase 3 DREAMM-8 study of belantamab mafodotin plus pomalidomide and dexamethasone (BPd) vs pomalidomide plus bortezomib and dexamethasone (PVd) in relapsed/refractory ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Fill out the form below and we'll send your colleague an invitation to the "Innovations in Biopharma 2025" event. The landscape of therapeutic development is being radically reshaped by rapid ...